P310: Intestinal ultrasound as a tool to assess treatment response in patients with Inflammatory Bowel DiseasesECCO'24Year: 2024
Authors: KatsarosMD, M.(1)*;Katsoula, A.(1);Kalogirou, M.(1);Paschos, P.(2);Papagiannakis, P.(1);Tsionis, T.(1);Giouleme, O.(1);
(1)Hippokration Hospital, Gastroenterology Division- Second Propaedeutic Department of Internal Medicine- Medical School- Aristotle University of Thessaloniki, Thessaloniki, Greece;(2)@D@Papageorgiou@D@ Hospital, First Department of Internal Medicine, Thessaloniki, Greece;
P311: Prevalence and impact of sarcopenia in patients with inflammatory bowel diseases: a prospective cohort study.ECCO'24Year: 2024
Authors: Nuzzo, A.(1)*;Adam Hassan, F.(2);Dermine, S.(3);Mohamed Gouse, A.(2);Billiauws, L.(2);Bourdillel, J.(2);Joly, F.(2);
(1)Hospital Beaujon, Department of Gastroenterology- IBD and Intestinal Failure, Clichy, France;(2)Beaujon Hospital, Gastroenterology- IBD- Intestinal Failure, Clichy, France;(3)Beaujon Hospital, Gastroenteroloy- IBD- Intestinal Failure, Clichy, France;
P312: Questionnaire survey for IBD patients in Japan; A Web-based J-CUP SurveyECCO'24Year: 2024
Authors: Goda, Y.(1)*;Matsumoto, T.(2);Imai, K.(1);Fujimitsu, Y.(1);Kajioka, T.(1);Kihara, H.(1);Funaki, Y.(3);Imaki, S.(4);Ueno, M.(1);
(1)EA pharma, Department of IBD Strategy, Tokyo, Japan;(2)Iwate Medical University, Division of Gastroenterology- Department of Internal Medicine, Morioka, Japan;(3)EA Pharma, Department of Integrated Marketing, Tokyo, Japan;(4)EA Pharma, Department of Corporate Communication, Tokyo, Japan;
P313: Panenteric capsule endoscopy in the investigation and assessment of Crohn’s disease at a tertiary centreECCO'24Year: 2024
Authors: Angadi, N.(1)*;Badat , S.(1);Villa, M.(1);Edward, S.(1);Willsmore, J.(1);Paul , H.(1);Bloom , S.(1);McCartney, S.(1);Rahman, F.(1);Magee, C.(1);Parisi, I.(1);
(1)University College London Hospital, Department of Gastroenterology, London, United Kingdom;
P315: Comparable un-passed patency capsule rates among Crohn’s disease patients during Clinical remission using different preparation protocolsECCO'24Year: 2024
Authors: Ukashi, O.(1,2)*;Dotan, A.(1,2);Borkovsky, T.(2,3);Talan Asher, A.(1,2);Thurm, T.(2,3);Hirsch, A.(2,3);Maharshak, N.(2,3);Eliakim, R.(1,2);Ben-Horin, S.(1,2);Kopylov, U.(1,2);Deutsch, L.(2,3);
(1)Sheba Medical Center Tel Hashomer, Gastroenterology Institute, Ramat gan, Israel;(2)Tel-Aviv University, School of Medicine, Tel-aviv, Israel;(3)Tel-Aviv Sourasky Medical Center, Department of Gastroenterology and Liver Diseases, Tel-aviv, Israel;
P317: Diagnostic accuracy of plasma calprotectin and serum calprotectin in patients with suspected Crohn’s diseaseECCO'24Year: 2024
Authors: Rasmussen, M.H.(1)*;Brodersen, J.B.(1);Brasen, C.L.(2);Madsen, J.S.(2);Knudsen, T.(1);Kjeldsen, J.(3);Jensen, M.D.(1);
(1)Hospital of South West Jutland – University Hospital of Southern Denmark, Department of Internal Medicine- Section of Gastroenterology, Esbjerg, Denmark;(2)Lillebaelt Hospital – University Hospital of Southern Denmark, Department of Clinical Biochemistry and Immunology, Vejle, Denmark;(3)Odense University Hospital, Department of Medical Gastroenterology, Odense, Denmark;
P318: Performance of rectosigmoidoscopy and rectoscopy to assess endoscopic and histological healing in ulcerative colitisECCO'24Year: 2024
Authors: Yzet, C.(1)*;Moreau, C.(1);Chatelain, D.(2);Meudjo, E.(1);Brazier, F.(1);Hautefeuille, V.(1);Robert, C.(1);Decrombecque, C.(1);Sarba, R.(1);Pichois, R.(3);Michaud, A.(4);Fumery, M.(1);
(1)CHU Amiens Picardie, Gastroenterology, Amiens, France;(2)CHU Amiens Picardie, Pathology, Amiens, France;(3)CHU Amiens Picardie, Radiology, Amiens, France;(4)CHU Amiens Picardie, Statistics, Amiens, France;
P319: Genetic polymorphism of lactose intolerance in patients with Inflammatory Bowel DiseaseECCO'24Year: 2024
Authors: Babayeva-Sadigova, G.(1)*;Guliyev, F.(2);Maxmudov , U.(3);Hasanov , R.(1,4);Musayev , J.(5);Asadova , G.(1,2);Ibrahimli , H.(6);Afandiyeva , N.(2);Hasanova , A.(1);Maharramova , T.(1,2);
(1)Azerbaijan State Advanced Training Institute for Doctors named after A.Aliyev, department of Therapy, Baku, Azerbaijan;(2)National Center of Oncology, Department of Invasive Diagnostics and Treatment, Baku, Azerbaijan;(3)Modern Hospital, Department of Gasmtroenterology and Endoscopy, Baku, Azerbaijan;(4)German Hospital, Department of Gasmtroenterology and Endoscopy, Baku, Azerbaijan;(5)Baku Pathology Center, Department of Pathology, Baku, Azerbaijan;(6)Azerbaijan State Advanced Training Institute for Doctors named after A.Aliyev, department of health organization, Baku, Azerbaijan;IBD
P320: Impact of Enterography on the Outcomes of Endoscopic Balloon Dilation for Ileocolonic Anastomotic Strictures in Crohn@E@s DiseaseECCO'24Year: 2024
Authors: Goncalves, J.(1,2,3)*;Lima Capela, T.(1,2,3);Cúrdia Gonçalves, T.(1,2,3);Magalhães, J.(1,2,3);Rosa, B.(1,2,3);Cotter, J.(1,2,3);
(1)Hospital da Senhora da Oliveira, Gastroenterology, Guimarães, Portugal;(2)Life and Health Sciences Research Institute ICVS- School of Medicine, University of Minho, Braga, Portugal;(3)ICVS/3B@E@s, PT Government Associate Laboratory, Braga/Guimarães, Portugal;
P321: Development and validation of an Integrated Risk Score for future risk of Crohn’s disease in healthy first-degree relatives: The CCC-GEM Project, a multicentre prospective cohort studyECCO'24Year: 2024
Authors: LeeDr., S.H.(1)*;Turpin, W.(1);Espin-Garcia, O.(2);Leibovitzh, H.(1);Xue, M.(1);Raygoza-Garay, J.A.(1);Grana, L.(3);Smith, M.I.(1);Goethel, A.(1);Madsen L., K.(4);Avni-Biron, I.(5);Dotan, I.(5);Shomron, B.H.(6);Griffiths, A.M.(7);Steinhart, A.H.(1);Silverberg, M.S.(1);Turner, D.(8);Bernstein, C.N.(9);Feagan, B.G.(10);Moayeddi, P.(11);Paterson, A.(12);Guttman, D.(3);Xu, W.(2);Croitoru, K.(1);
(1)Mount Sinai Hospital- University of Toronto, Division of Gastroenterology, Toronto, Canada;(2)Dalla Lana School of Public Health- University of Toronto, Division of Biostatistics, Toronto, Canada;(3)University of Toronto, Centre for the Analysis of Genome Evolution and Function, Toronto, Canada;(4)University of Alberta, Department of Medicine, Edmonton, Canada;(5)Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel;(6)Sheba Medical Center, Division of Gastroenterology, Tel Aviv, Israel;(7)The Hospital for Sick Children, Division of Gastroenterology, Toronto, Canada;(8)Shaare Zedek Medical Center- The Hebrew University of Jerusalem, The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Toronto, Canada;(9)University of Manitoba, Inflammatory Bowel Disease Clinical and Research Centre, Manitoba, Canada;(10)University of Western Ontario, Departments of Medicine- Epidemiology- and Biostatistics, Toronto, Canada;(11)McMaster University, Farncombe Family Digestive Health Research Institute, Toronto, Canada;(12)The Hospital for Sick Children, Genetics and Genome Biology, Toronto, Canada;The Crohn@E@s Colitis Canada GEM Project Research Consortium
P322: Compared Efficacy of Second-Line Treatments for Ulcerative Colitis After Failure of Vedolizumab in First-Line Treatment: A Retrospective Multicenter StudyECCO'24Year: 2024
Authors: Calmejane, L.(1);Reenaers, C.(2);Amiot, A.(3);Nuzzo, A.(4);Vuitton, L.(5);Altwegg, R.(6);Guillo, L.(7);Wils, P.(8);Roblin, X.(9);Le Cosquer, G.(10);Simon, M.(11);Benezech, A.(12);Laharie, D.(13);Fumery, M.(14);Buisson, A.(15);Charkaoui, M.(16);Nancey, S.(17);Sabra, G.(18);Geyl, S.(19);Coffin, B.(20);Cavicchi, M.(21);Le Berre, C.(22);Goutorbe, F.(23);Bouguen, G.(24);Vidon, M.(25);Christmann, P.Y.(26);Kirchgesner, J.(27);Uzzan, M.(28)*;
(1)CHU Mondor, Gastro, Creteil, France;(2)CHU Liege, Gastro, Liege, Belgium;(3)Hopital Bicetre, Gastro, Kremlin Bicetre, France;(4)Hopital Beaujon, Gastro, Cllichy, France;(5)CHU Besancon, Gastro, Besancon, France;(6)CHU Montpellier, Gastro, Montpellier, France;(7)Hopital Nord, Gastro, Marseille, France;(8)CHU Lille, Gastro, Lille, France;(9)CHU Saint Etienne, Gastro, Saint Etienne, France;(10)CHU Toulouse, Gastro, Toulouse, France;(11)CHU Saint Louis, Gastro, Paris, France;(12)CH Avigon, Gastro, Avignon, France;(13)CHU Bordeaux, Gastro, Bordeaux, France;(14)CHU Amiens, Gastro, Amiens, France;(15)CHU Clermont, Gastro, Clermont Ferrand, France;(16)CHU dijon, Gastro, Dijon, France;(17)CHU Lyon, Gastro, Lyon, France;(18)CH Saint Malo, Gastro, Saint Malo, France;(19)CHU Limoges, Gastro, Limoges, France;(20)CHU Louis Mourier, Gastro, Colombes, France;(21)Clinique de Bercy, Gastro, Créteil, France;(22)CHU Nantes, Gastro, Nantes, France;(23)CH Bayonne, Gastro, Bayonne, France;(24)CHU Rennes, Gastro, Rennes, France;(25)CHI Creteil, Gastro, Creteil, France;(26)CHU Strasbourg, Gastro, Strasbourg, France;(27)Hopital Saint Antoine, Gastro, Paris, France;(28)Hopital Henri Mondor, Department of Gastroenterology, Créteil, France;
P323: Defining Normal Bowel Wall Thickness on Intestinal Ultrasound in an International Multicenter Cohort of Children with Inflammatory Bowel Disease in Sustained Deep RemissionECCO'24Year: 2024
Authors: Kellar, A.(1)*;Chavannes, M.(2);Huynh, H.(3);Aronskyy, I.(4);DeBruyn, J.(5);Kim, J.(6);Dolinger, M.(7);
(1)University of Chicago, Section of Pediatric Gastroenterology- Hepatology and Nutrition, Chicago, United States;(2)Children’s Hospital Los Angeles- Keck School of Medicine of the University of Southern California, Division of Gastroenterology- Hepatology- and Nutrition, Los Angeles, United States;(3)University of Alberta, Department of Pediatrics- Division of Pediatric Gastroenterology and Nutrition, Edmonton, United States;(4)Icahn School of Medicine at Mount Sinai, Division of Pediatric Gastroenterology- Susan and Leonard Feinstein Inflammatory Bowel Disease Center, New York, United States;(5)University of Calgary, Department of Pediatrics- Division of Gastroenterology- Hepatology and Nutrition, Calgary, United States;(6)University of Alberta, Department of Pediatrics- Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics- Division of Pediatric Gastroenterology and Nutrition, United States;(7)Icahn School of Medicine at Mount Sinai, Department of Pediatrics- Division of Pediatric Gastroenterology- Susan and Leonard Feinstein Inflammatory Bowel Disease Center, New York, United States;
P324: Urine metabolite profile characterizes clinical activity and disease extent in patients with inflammatory bowel diseaseECCO'24Year: 2024
Authors: Balderramo, D.C.(1)*;Cuencas Barrientos , M.E.(2);Tantucci, L.(3);Cabrera, D.(4);Fernandez, M.(5);Fochesato, A.(6);Delgado, A.(6);Correa, S.(7);Romagnoli, P.(8);
(1)IBD Section, Gastroenterology Department. Hospital Privado Universitario de Cordoba. Instituto Universitario de Ciencias Biomedicas de Cordoba, Cordoba, Argentina;(2)Instituto Universitario de Ciencias Biomédicas de Córdoba IUCBC- Centro de Investigación en Medicina Traslacional “Severo R. Amuchástegui” CIMETSA, Instituto de Investigación Médica Mercedes y Martín Ferreyra INIMEC-CONICET-UNC, Cordoba, Argentina;(3)Fundación Para el Progreso de la Medicina, Servicio de Inmunología, Cordoba, Argentina;(4)Hospital Privado Universitario de Córdoba, Nutrition Department, Cordoba, Argentina;(5)Hospital Privado Universitario de Córdoba, Central Laboratory, Cordoba, Argentina;(6)Metabolomics Laboratory, Metabolomics Laboratory, Cordoba, Argentina;(7)Facultad de Ciencias Químicas- Universidad Nacional de Córdoba, Centro de Investigaciones en Bioquímica Clínica e Inmunología CIBICI, Cordoba, Argentina;(8)Instituto Universitario de Ciencias Biomédicas de Córdoba IUCBC- Instituto de Investigación Médica Mercedes y Martín Ferreyra INIMEC-CONICET-UNC, Centro de Investigación en Medicina Traslacional “Severo R. Amuchástegui” CIMETSA, Cordoba, Argentina;
P325: Post-COVID general health symptoms in patients with Immune Mediated Inflammatory DiseasesECCO'24Year: 2024
Authors: Van De Pol, N.(1)*;van der Woude, C.J.(1);Vis, M.(2);van Doorn, M.(3);Schrauwen, S.L.(4);Cetinözman-Teunissen, F.(5);West, R.L.(6);Pan, Q.(1);de Vries, A.C.(1);
(1)Erasmus University Medical Center, Gastroenterology and hepatology, Rotterdam, The Netherlands;(2)Erasmus University Medical Center, Rheumatology, Rotterdam, The Netherlands;(3)Erasmus University Medical Center, Dermatology, Rotterdam, The Netherlands;(4)Franciscus Gasthuis & Vlietland, Rheumatology, Rotterdam, The Netherlands;(5)Franciscus Gasthuis & Vlietland, Dermatology, Rotterdam, The Netherlands;(6)Franciscus Gasthuis & Vlietland, Gastroenterology and Hepatology, Rotterdam, The Netherlands;
P326: Impact of disease flares on resource use, health-related quality of life and productivity in untreated Crohn’s Disease patients in US: an analysis of national health and wellness survey dataECCO'24Year: 2024
Authors: Dubon-Garcia, A.(1);Naessens, D.(2);Pollack, P.(3);Sikirica, M.(1);Sanon, M.(1)*;
(1)Johnson & Johnson Innovative Medicine, Global Market Access Immunology, Horsham, United States;(2)Johnson & Johnson Innovative Medicine, Global Market Access Immunology, Beerse, Belgium;(3)Johnson & Johnson Innovative Medicine, Global Medical Affairs Immunology, Horsham, United States;
P327: Profiling serum metabolome and lipidome to differentiate primary sclerosing cholangitis from Inflammatory Bowel Disease and healthy controlsECCO'24Year: 2024
Authors: Fererberger, T.(1);Buechler, C.(1);Kandulski, A.(1);Elger, T.(1)*;Loibl, J.(1);Schmid, S.(1);Sommersberger, S.(1);Gunawan, S.(1);Zundler, S.(2,3);Bettenworth, D.(4,5);Kempa, S.(6);Weidlich, S.(7);Foeh, B.(8,9);Derer-Petersen , S.(8);Guenther, U.L.(10);Marquardt, J.U.(9);Kunst, C.(1);Guelow, K.(1);Mueller, M.(1);Sina, C.(8,9,11);Tews, H.C.(1);Schmelter, F.(8);
(1)University Hospital Regensburg, Department of Internal Medicine I- Gastroenterology- Hepatology- Endocrinology- Rheumatology- and Infectious Diseases, Regensburg, Germany;(2)University Hospital Erlangen, Department of Medicine I, Erlangen, Germany;(3)University Hospital Erlangen, Deutsches Zentrum Immuntherapie, Erlangen, Germany;(4)University Hospital Muenster, Department of Medicine B- Gastroenterology and Hepatology, Muenster, Germany;(5)Practice, Internal Medicine, Muenster, Germany;(6)University Hospital Regensburg, Department for Plastic- Hand- and Reconstructive Surgery, Regensburg, Germany;(7)Technical University of Munich- School of Medicine and Health- University Hospital Rechts der Isar, Department of Internal Medicine II, Munich, Germany;(8)University Medical Centre Schleswig-Holstein- Campus Luebeck, Institute of Nutritional Medicine, Luebeck, Germany;(9)University Medical Centre Schleswig-Holstein- Campus Luebeck, Department of Medicine I, Luebeck, Germany;(10)University of Luebeck, Institute of Chemistry and Metabolomics, Luebeck, Germany;(11)Fraunhofer Research Institution, Individualized and Cell-Based Medical Engineering IMTE, Luebeck, Germany;
P328: Ischemic Ulcers Do Not Significantly Impact The Endoscopic Recurrence Score In Crohn’s Disease: A Multicenter Comparative Study After Right-Side Resections For Crohn’s Disease And Colorectal CancerECCO'24Year: 2024
Authors: Luglio, G.(1)*;Castiglione, F.(2);Orlando, A.(3);Solina, G.(4);Fichera, A.(5);Imperatore, N.(6);Lamanda, R.(6);Di Girolamo, E.(7);Marone, P.(7);Delrio, P.(8);Tropeano, F.P.(2);Calabrese, G.(2);Cricrì, M.(2);Calderone, S.(3);Toro, B.(2);De Palma, G.D.(2);Rispo, A.(2);
(1)Federico II University Hospital, Public Health, Naples, Italy;(2)Federico II University Hospital, Clinical Medicine and Surgery, Naples, Italy;(3)Villa Sofia-Cervello Hospital, Inflammatory Bowel Disease Unit, Palermo, Italy;(4)Villa Sofia-Cervello Hospital, General Surgery Unit, Palermo, Italy;(5)Baylor University Medical Center, Colon and Rectal Surgery, Dallas, United States;(6)Santa Maria delle Grazie Hospital, Gastroenterology and Endoscopy Unit, Pozzuoli, Italy;(7)Istituto Nazionale Tumori-IRCCS @D@Fondazione G. Pascale@D@, Gastroenterology and Gastrointestinal Endoscopy, Naples, Italy;(8)Istituto Nazionale Tumori-IRCCS @D@Fondazione G. Pascale@D@, Colorectal Surgical Oncology, Naples, Italy;
P329: Sarcopenia is a risk factor of post-operative recurrence of Crohn’s diseaseECCO'24Year: 2024
Authors: Ceccarelli, L.(1);Rosi, E.M.(1)*;Scandiffio, R.(2);Neri, C.M.(3);Fe@E@, P.(1);Fornaroli, G.(1);Comparato, C.(1);Berti, G.(1);Baiano Svizzero, G.(1);Mumolo, M.G.(1);D@E@Ischia, R.(3);de Bortoli, N.(4);Bellini, M.(4);Franceschi, M.(3);Costa, F.(1);
(1)University of Pisa, Department of Surgery- IBD Unit, Pisa, Italy;(2)University of Pisa, Department of Interventional Radiology, Pisa, Italy;(3)University of Pisa, Department of Surgery- IBD Surgery, Pisa, Italy;(4)University of Pisa, Department of Traslational Research and New Technology in Medicine and Surgery- Pisa University Hospital, Pisa, Italy;
P330: Rate of disability at diagnosis in patients with inflammatory bowel diseases: Results from a prospective population-based inception cohort, IBD Prognosis StudyECCO'24Year: 2024
Authors: Attauabi, M.(1,2,3)*;Madsen, G.R.(2,3);Bendtsen, F.(2,3);Seidelin, J.(1);Burisch, J.(2,3);
(1)Copenhagen University Hospital - Herlev and Gentofte, Department of Gastroenterology and Hepatology, Herlev, Denmark;(2)Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents- and Adults, Hvidovre, Denmark;(3)Copenhagen University Hospital - Amager and Hvidovre, Gastrounit- Medical Section, Hvidovre, Denmark;
